Long-Acting Lipoglycopeptides for Skin and Soft Tissue Infections : Implementation Into Practice

In this episode, Kyle Molina, PharmD, BCIDP, discusses key considerations for successful implementation of long-acting lipoglycopeptides into clinical practice. Listen as he gives perspectives on:

• Reasons to consider use of long-acting lipoglycopeptides (eg, poor adherence to oral antibiotics, PICC-related costs and complications)
• Data supporting and challenging cost effectiveness of long-acting lipoglycopeptides 
• Identifying the target patient population
• Selecting the right location to provide long-acting lipoglycopeptides 
• Strategies to maximize institutional impact with key stakeholders (eg, hospital avoidance, reduced ED and hospital length of stay) 
• Key characteristics of available long-acting lipoglycopeptides 
• Addressing logistical challenges, including navigating the reimbursement process

Faculty:

Kyle Molina, PharmD, BCIDP
Infectious Diseases Clinical Pharmacist
Scripps Green Hospital
La Jolla, California

Link to full program: 

• CCO: https://bit.ly/3J4mg8h
• ProCE: https://bit.ly/3P0vB4E

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.